AJP - Regu Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 293: R209-R222, 2007. First published March 15, 2007; doi:10.1152/ajpregu.00099.2006
0363-6119/07 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
293/1/R209    most recent
00099.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Oakley, R. H.
Right arrow Articles by Hauger, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oakley, R. H.
Right arrow Articles by Hauger, R. L.

NEUROHUMORAL CONTROL OF CARDIOVASCULAR FUNCTION

Carboxyl-terminal and intracellular loop sites for CRF1 receptor phosphorylation and beta-arrestin-2 recruitment: a mechanism regulating stress and anxiety responses

Robert H. Oakley,1,* J. Alberto Olivares-Reyes,2,* Christine C. Hudson,1 Fabiola Flores-Vega,2 Frank M. Dautzenberg,3 and Richard L. Hauger4

1Xsira Pharmaceuticals, Morrisville, North Carolina; 2Departamento de Bioquimica, Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional, Mexico City, Mexico; 3Johnson & Johnson Pharmaceuticals Research & Development, CNS Drug Discovery, Beerse, Belgium; and 4Veterans Affairs Healthcare System and Department of Psychiatry, University of California, San Diego, La Jolla, California

Submitted 7 February 2006 ; accepted in final form 27 February 2007

The primary goal was to test the hypothesis that agonist-induced corticotropin-releasing factor type 1 (CRF1) receptor phosphorylation is required for beta-arrestins to translocate from cytosol to the cell membrane. We also sought to determine the relative importance to beta-arrestin recruitment of motifs in the CRF1 receptor carboxyl terminus and third intracellular loop. beta-Arrestin-2 translocated significantly more rapidly than beta-arrestin-1 to agonist-activated membrane CRF1 receptors in multiple cell lines. Although CRF1 receptors internalized with agonist treatment, neither arrestin isoform trafficked with the receptor inside the cell, indicating that CRF1 receptor-arrestin complexes dissociate at or near the cell membrane. Both arrestin and clathrin-dependent mechanisms were involved in CRF1 receptor internalization. To investigate molecular determinants mediating the robust beta-arrestin-2-CRF1 receptor interaction, mutagenesis was performed to remove potential G protein-coupled receptor kinase phosphorylation sites. Truncating the CRF1 receptor carboxyl terminus at serine-386 greatly reduced agonist-dependent phosphorylation but only partially impaired beta-arrestin-2 recruitment. Removal of a serine/threonine cluster in the third intracellular loop also significantly reduced CRF1 receptor phosphorylation but did not alter beta-arrestin-2 recruitment. Phosphorylation was abolished in a CRF1 receptor possessing both mutations. Surprisingly, this mutant still recruited beta-arrestin-2. These mutations did not alter membrane expression or cAMP signaling of CRF1 receptors. Our data reveal the involvement of at least the following two distinct receptor regions in beta-arrestin-2 recruitment: 1) a carboxyl-terminal motif in which serine/threonine residues must be phosphorylated and 2) an intracellular loop motif configured by agonist-induced changes in CRF1 receptor conformation. Deficient beta-arrestin-2-CRF1 receptor interactions could contribute to the pathophysiology of affective disorders by inducing excessive CRF1 receptor signaling.

corticotropin-releasing factor; G protein-coupled receptor kinase; receptor phosphorylation; internalization; stress adaptation



Address for reprint requests and other correspondence: R. Hauger, Dept. of Psychiatry, Univ. of California, San Diego, 9500 Gilman Dr., La Jolla, CA 92093-0603 (e-mail address: rhauger{at}ucsd.edu)




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
E. Gutknecht, I. Van der Linden, K. Van Kolen, K. F. C. Verhoeven, G. Vauquelin, and F. M. Dautzenberg
Molecular Mechanisms of Corticotropin-Releasing Factor Receptor-Induced Calcium Signaling
Mol. Pharmacol., March 1, 2009; 75(3): 648 - 657.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.